Mark A. Berman, Chief Medical Officer: Better Therapeutics BTTX Buy · Filed 23/07/31

Trade details

Type: Insider buy
Amount: $40,005.46
Shares · price: 54,802 sh · $0.73 a share
Held after: 388,191 sh
Stock: Better Therapeutics BTTX
Person: Mark A. BermanChief Medical Officer
Trade date: 23/07/27
Filed: 23/07/31
Days to filing: 4 days

6 insiders bought this week

Insiders buying this week: 6 insiders
Holding change: +16.4%

Better Therapeutics trades, last 26 weeks

What else happened in Better Therapeutics around then

Filed or reported within 30 days of the trade day · 23/06/27~23/08/26

Mark A. Berman's recent trades

No other trades yet.